This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Maija Horsmanheimo, MD; Kai Krohn, MD; Martti Virolainen, MD; Kirsti Blomqvist, MD

Arch Dermatol. 1979;115(2):180-184.

Abstract
We report the acquisition of skin test sensitivity to Candida albicans antigen and the ability to produce leukocyte migration inhibition factor (MIF) by a Candida-negative patient with chronic granulomatous mucocutaneous candidiasis after treatment with dialyzable transfer factor (TFd). The TFd was acquired from Candida-positive healthy donors. Three of seven attempts to transfer Candida skin test sensitivity were successful, and the acquired skin reactivity lasted for 12 to 21 days. The acquisition of cellular immunity to Candida was demonstrated in vitro by production of leukocyte MIF. No Candida-induced lymphocyte transformation was observed before or after TFd injection. The TFd did not cause Candida-induced blast transformation when added directly to cultures of lymphocytes from the patient. Pain, tenderness, redness, and edema were observed around the Candida granulomas on each occasion when the skin test to Candida became positive. Two weeks after TFd injection, the proliferative response of peripheral blood lymphocytes increased, as measured by incorporation of tritiated thymidine into lymphocytes within the first hour of in vitro incubation.

(Arch Dermatol 115:180-184, 1979)

Author Affiliations
From the Department of Dermatology, University Central Hospital, Helsinki (Drs Horsmanheimo and Blomqvist); the Department of Biomedical Sciences, School of Medicine, University of Tampere, Finland (Dr Krohn); and Third Department of Pathology, University of Helsinki (Drs Horsmanheimo and Virolainen).

Footnotes
Accepted for publication Aug 28, 1978.

Reprint requests to Department of Dermatology, University of Kuopio, 70210 Kuopio 21, Finland (Dr Horsmanheimo).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cimetidine as an Immunomodulator: Chronic Mucocutaneous Candidiasis as a Model
JORIZZO et al.
ANN INTERN MED 1980;92:192-195.
ABSTRACT